nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—Nephropathy—Vandetanib—thyroid cancer	0.0243	0.0516	CcSEcCtD
Epinephrine—Ischaemia—Sorafenib—thyroid cancer	0.0214	0.0454	CcSEcCtD
Epinephrine—Tachyarrhythmia—Epirubicin—thyroid cancer	0.0158	0.0335	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.0156	0.0332	CcSEcCtD
Epinephrine—Tachyarrhythmia—Doxorubicin—thyroid cancer	0.0146	0.031	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Sorafenib—thyroid cancer	0.0141	0.0299	CcSEcCtD
Epinephrine—Lactic acidosis—Epirubicin—thyroid cancer	0.0118	0.0251	CcSEcCtD
Epinephrine—Lactic acidosis—Doxorubicin—thyroid cancer	0.0109	0.0232	CcSEcCtD
Epinephrine—Myocardial ischaemia—Sorafenib—thyroid cancer	0.0097	0.0206	CcSEcCtD
Epinephrine—Hypoglycaemia—Vandetanib—thyroid cancer	0.0086	0.0183	CcSEcCtD
Epinephrine—Drug interaction—Sorafenib—thyroid cancer	0.00841	0.0179	CcSEcCtD
Epinephrine—Skin necrosis—Epirubicin—thyroid cancer	0.00825	0.0175	CcSEcCtD
Epinephrine—Hemiplegia—Epirubicin—thyroid cancer	0.00807	0.0171	CcSEcCtD
Epinephrine—Blood pressure increased—Sorafenib—thyroid cancer	0.0078	0.0166	CcSEcCtD
Epinephrine—Hypokalaemia—Vandetanib—thyroid cancer	0.00764	0.0162	CcSEcCtD
Epinephrine—Skin necrosis—Doxorubicin—thyroid cancer	0.00763	0.0162	CcSEcCtD
Epinephrine—Hemiplegia—Doxorubicin—thyroid cancer	0.00747	0.0159	CcSEcCtD
Epinephrine—Skin exfoliation—Sorafenib—thyroid cancer	0.00745	0.0158	CcSEcCtD
Epinephrine—Hyperglycaemia—Vandetanib—thyroid cancer	0.00654	0.0139	CcSEcCtD
Epinephrine—Renal failure—Vandetanib—thyroid cancer	0.00636	0.0135	CcSEcCtD
Epinephrine—Haemoglobin—Vandetanib—thyroid cancer	0.00584	0.0124	CcSEcCtD
Epinephrine—Haemorrhage—Vandetanib—thyroid cancer	0.00581	0.0123	CcSEcCtD
Epinephrine—Local reaction—Epirubicin—thyroid cancer	0.00521	0.0111	CcSEcCtD
Epinephrine—Arrhythmia—Vandetanib—thyroid cancer	0.00519	0.011	CcSEcCtD
Epinephrine—Hypokalaemia—Sorafenib—thyroid cancer	0.00515	0.0109	CcSEcCtD
Epinephrine—Mental disorder—Vandetanib—thyroid cancer	0.00509	0.0108	CcSEcCtD
Epinephrine—Local reaction—Doxorubicin—thyroid cancer	0.00482	0.0102	CcSEcCtD
Epinephrine—Hypertension—Vandetanib—thyroid cancer	0.00436	0.00927	CcSEcCtD
Epinephrine—Chest pain—Vandetanib—thyroid cancer	0.0043	0.00914	CcSEcCtD
Epinephrine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.0043	0.00914	CcSEcCtD
Epinephrine—Renal failure—Sorafenib—thyroid cancer	0.00429	0.00911	CcSEcCtD
Epinephrine—Myocardial infarction—Sorafenib—thyroid cancer	0.00428	0.00908	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00427	0.00908	CcSEcCtD
Epinephrine—Nervous system disorder—Vandetanib—thyroid cancer	0.00404	0.00859	CcSEcCtD
Epinephrine—Skin disorder—Vandetanib—thyroid cancer	0.00401	0.00851	CcSEcCtD
Epinephrine—Haemoglobin—Sorafenib—thyroid cancer	0.00394	0.00836	CcSEcCtD
Epinephrine—Haemorrhage—Sorafenib—thyroid cancer	0.00392	0.00832	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00389	0.00827	CcSEcCtD
Epinephrine—Insomnia—Vandetanib—thyroid cancer	0.00373	0.00793	CcSEcCtD
Epinephrine—Paraesthesia—Vandetanib—thyroid cancer	0.0037	0.00787	CcSEcCtD
Epinephrine—Necrosis—Epirubicin—thyroid cancer	0.00367	0.0078	CcSEcCtD
Epinephrine—Flushing—Sorafenib—thyroid cancer	0.00363	0.00772	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.0036	0.00765	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00356	0.00757	CcSEcCtD
Epinephrine—Arrhythmia—Sorafenib—thyroid cancer	0.0035	0.00743	CcSEcCtD
Epinephrine—Mental disorder—Sorafenib—thyroid cancer	0.00343	0.00729	CcSEcCtD
Epinephrine—Erythema—Sorafenib—thyroid cancer	0.00341	0.00724	CcSEcCtD
Epinephrine—Necrosis—Doxorubicin—thyroid cancer	0.0034	0.00722	CcSEcCtD
Epinephrine—Extravasation—Epirubicin—thyroid cancer	0.0033	0.00702	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00319	0.00678	CcSEcCtD
Epinephrine—Extravasation—Doxorubicin—thyroid cancer	0.00306	0.00649	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00295	0.00627	CcSEcCtD
Epinephrine—Hypertension—Sorafenib—thyroid cancer	0.00294	0.00625	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00288	0.00612	CcSEcCtD
Epinephrine—Skin exfoliation—Epirubicin—thyroid cancer	0.00275	0.00585	CcSEcCtD
Epinephrine—Nervous system disorder—Sorafenib—thyroid cancer	0.00273	0.0058	CcSEcCtD
Epinephrine—Dizziness—Vandetanib—thyroid cancer	0.00273	0.00579	CcSEcCtD
Epinephrine—Skin disorder—Sorafenib—thyroid cancer	0.0027	0.00574	CcSEcCtD
Epinephrine—Vomiting—Vandetanib—thyroid cancer	0.00262	0.00557	CcSEcCtD
Epinephrine—Pulmonary oedema—Epirubicin—thyroid cancer	0.00257	0.00545	CcSEcCtD
Epinephrine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00255	0.00541	CcSEcCtD
Epinephrine—Nausea—Vandetanib—thyroid cancer	0.00245	0.0052	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0024	0.0051	CcSEcCtD
Epinephrine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00237	0.00504	CcSEcCtD
Epinephrine—Renal impairment—Epirubicin—thyroid cancer	0.0022	0.00467	CcSEcCtD
Epinephrine—Hypoglycaemia—Epirubicin—thyroid cancer	0.00214	0.00455	CcSEcCtD
Epinephrine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00213	0.00454	CcSEcCtD
Epinephrine—Renal impairment—Doxorubicin—thyroid cancer	0.00203	0.00432	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00198	0.00421	CcSEcCtD
Epinephrine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00198	0.0042	CcSEcCtD
Epinephrine—Hypokalaemia—Epirubicin—thyroid cancer	0.0019	0.00405	CcSEcCtD
Epinephrine—Dizziness—Sorafenib—thyroid cancer	0.00184	0.00391	CcSEcCtD
Epinephrine—Vomiting—Sorafenib—thyroid cancer	0.00177	0.00376	CcSEcCtD
Epinephrine—Hypokalaemia—Doxorubicin—thyroid cancer	0.00176	0.00374	CcSEcCtD
Epinephrine—Nausea—Sorafenib—thyroid cancer	0.00165	0.00351	CcSEcCtD
Epinephrine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00163	0.00347	CcSEcCtD
Epinephrine—Drowsiness—Epirubicin—thyroid cancer	0.00161	0.00343	CcSEcCtD
Epinephrine—Renal failure—Epirubicin—thyroid cancer	0.00158	0.00337	CcSEcCtD
Epinephrine—Sweating—Epirubicin—thyroid cancer	0.00155	0.00328	CcSEcCtD
Epinephrine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00151	0.00321	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—thyroid cancer	0.00149	0.00317	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—thyroid cancer	0.00147	0.00312	CcSEcCtD
Epinephrine—Haemoglobin—Epirubicin—thyroid cancer	0.00145	0.00309	CcSEcCtD
Epinephrine—Haemorrhage—Epirubicin—thyroid cancer	0.00145	0.00307	CcSEcCtD
Epinephrine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00144	0.00306	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—thyroid cancer	0.00143	0.00304	CcSEcCtD
Epinephrine—Haemoglobin—Doxorubicin—thyroid cancer	0.00135	0.00286	CcSEcCtD
Epinephrine—Flushing—Epirubicin—thyroid cancer	0.00134	0.00285	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—thyroid cancer	0.00134	0.00285	CcSEcCtD
Epinephrine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00133	0.00283	CcSEcCtD
Epinephrine—Arrhythmia—Epirubicin—thyroid cancer	0.00129	0.00275	CcSEcCtD
Epinephrine—Mental disorder—Epirubicin—thyroid cancer	0.00127	0.00269	CcSEcCtD
Epinephrine—Erythema—Epirubicin—thyroid cancer	0.00126	0.00268	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—thyroid cancer	0.00124	0.00264	CcSEcCtD
Epinephrine—Tension—Epirubicin—thyroid cancer	0.00124	0.00263	CcSEcCtD
Epinephrine—Nervousness—Epirubicin—thyroid cancer	0.00122	0.0026	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—thyroid cancer	0.0012	0.00254	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—thyroid cancer	0.00117	0.00249	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—thyroid cancer	0.00117	0.00248	CcSEcCtD
Epinephrine—Agitation—Epirubicin—thyroid cancer	0.00116	0.00246	CcSEcCtD
Epinephrine—Tension—Doxorubicin—thyroid cancer	0.00114	0.00243	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—thyroid cancer	0.00113	0.00241	CcSEcCtD
Epinephrine—Palpitations—Epirubicin—thyroid cancer	0.00111	0.00237	CcSEcCtD
Epinephrine—Hypertension—Epirubicin—thyroid cancer	0.00109	0.00231	CcSEcCtD
Epinephrine—Chest pain—Epirubicin—thyroid cancer	0.00107	0.00228	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—thyroid cancer	0.00107	0.00228	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00107	0.00226	CcSEcCtD
Epinephrine—Palpitations—Doxorubicin—thyroid cancer	0.00103	0.00219	CcSEcCtD
Epinephrine—Nervous system disorder—Epirubicin—thyroid cancer	0.00101	0.00214	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—thyroid cancer	0.00101	0.00214	CcSEcCtD
Epinephrine—Tachycardia—Epirubicin—thyroid cancer	0.001	0.00213	CcSEcCtD
Epinephrine—Skin disorder—Epirubicin—thyroid cancer	0.000999	0.00212	CcSEcCtD
Epinephrine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000994	0.00211	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—thyroid cancer	0.000992	0.00211	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000986	0.00209	CcSEcCtD
Epinephrine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000933	0.00198	CcSEcCtD
Epinephrine—Insomnia—Epirubicin—thyroid cancer	0.00093	0.00198	CcSEcCtD
Epinephrine—Tachycardia—Doxorubicin—thyroid cancer	0.000929	0.00197	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—thyroid cancer	0.000924	0.00196	CcSEcCtD
Epinephrine—Paraesthesia—Epirubicin—thyroid cancer	0.000923	0.00196	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00092	0.00195	CcSEcCtD
Epinephrine—Somnolence—Epirubicin—thyroid cancer	0.000914	0.00194	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000888	0.00189	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—thyroid cancer	0.000861	0.00183	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—thyroid cancer	0.000854	0.00182	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—thyroid cancer	0.000846	0.0018	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000821	0.00175	CcSEcCtD
Epinephrine—Dizziness—Epirubicin—thyroid cancer	0.00068	0.00144	CcSEcCtD
Epinephrine—Vomiting—Epirubicin—thyroid cancer	0.000654	0.00139	CcSEcCtD
Epinephrine—Dizziness—Doxorubicin—thyroid cancer	0.000629	0.00134	CcSEcCtD
Epinephrine—Nausea—Epirubicin—thyroid cancer	0.000611	0.0013	CcSEcCtD
Epinephrine—Vomiting—Doxorubicin—thyroid cancer	0.000605	0.00129	CcSEcCtD
Epinephrine—Nausea—Doxorubicin—thyroid cancer	0.000565	0.0012	CcSEcCtD
Epinephrine—PAH—Disease—AKT1—thyroid cancer	0.000109	0.000207	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CALCA—thyroid cancer	0.000108	0.000205	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—NRAS—thyroid cancer	0.000108	0.000204	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SST—thyroid cancer	0.000107	0.000201	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—RXRA—thyroid cancer	0.000106	0.0002	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—NRAS—thyroid cancer	0.000105	0.000199	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SST—thyroid cancer	0.000105	0.000198	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	0.000105	0.000198	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000104	0.000196	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—RXRA—thyroid cancer	0.000103	0.000195	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—NRAS—thyroid cancer	0.000103	0.000194	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CALCA—thyroid cancer	0.000103	0.000194	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	0.000102	0.000193	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CALCA—thyroid cancer	0.000101	0.000191	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—KRAS—thyroid cancer	0.000101	0.00019	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDK1—thyroid cancer	0.0001	0.00019	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.0001	0.000189	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—SLC5A5—thyroid cancer	9.97e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	9.95e-05	0.000188	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—RXRA—thyroid cancer	9.88e-05	0.000187	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HPGD—thyroid cancer	9.88e-05	0.000187	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—NRAS—thyroid cancer	9.83e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDK1—thyroid cancer	9.82e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—BRAF—thyroid cancer	9.65e-05	0.000182	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	9.47e-05	0.000179	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—HRAS—thyroid cancer	9.39e-05	0.000177	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—HRAS—thyroid cancer	9.36e-05	0.000177	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SST—thyroid cancer	9.32e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDK1—thyroid cancer	9.29e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—KRAS—thyroid cancer	9.29e-05	0.000175	CbGpPWpGaD
Epinephrine—PAH—Metabolism—AKT1—thyroid cancer	9.16e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDK1—thyroid cancer	9.14e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—AKT1—thyroid cancer	9.1e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—KRAS—thyroid cancer	9.06e-05	0.000171	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	8.97e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRG1—thyroid cancer	8.84e-05	0.000167	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—KRAS—thyroid cancer	8.84e-05	0.000167	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CCND1—thyroid cancer	8.77e-05	0.000166	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SST—thyroid cancer	8.66e-05	0.000164	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TPR—thyroid cancer	8.6e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HRAS—thyroid cancer	8.55e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—PTEN—thyroid cancer	8.47e-05	0.00016	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	8.46e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—KRAS—thyroid cancer	8.46e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—RXRA—thyroid cancer	8.38e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	8.34e-05	0.000157	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—AKT1—thyroid cancer	8.29e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—AKT1—thyroid cancer	8.26e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	8.12e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRG1—thyroid cancer	8.06e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—thyroid cancer	8.05e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—NRAS—thyroid cancer	7.98e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	7.98e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TERT—thyroid cancer	7.94e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HRAS—thyroid cancer	7.89e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRG1—thyroid cancer	7.88e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—HRAS—thyroid cancer	7.7e-05	0.000145	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.67e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	7.59e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—NRAS—thyroid cancer	7.56e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—AKT1—thyroid cancer	7.55e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	7.55e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—thyroid cancer	7.52e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HRAS—thyroid cancer	7.51e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	7.46e-05	0.000141	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TPR—thyroid cancer	7.35e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	7.34e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—AKT1—thyroid cancer	7.3e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TERT—thyroid cancer	7.23e-05	0.000137	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	7.23e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—HRAS—thyroid cancer	7.19e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	7.17e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TERT—thyroid cancer	7.08e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCND1—thyroid cancer	7.04e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—AKT1—thyroid cancer	6.97e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HIF1A—thyroid cancer	6.92e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—KRAS—thyroid cancer	6.87e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	6.85e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PTEN—thyroid cancer	6.8e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—AKT1—thyroid cancer	6.8e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HIF1A—thyroid cancer	6.77e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TERT—thyroid cancer	6.7e-05	0.000126	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PPARG—thyroid cancer	6.69e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	6.69e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—AKT1—thyroid cancer	6.63e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TERT—thyroid cancer	6.59e-05	0.000124	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.56e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	6.52e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PPARG—thyroid cancer	6.51e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—KRAS—thyroid cancer	6.5e-05	0.000123	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	6.44e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	6.4e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—AKT1—thyroid cancer	6.35e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	6.3e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	6.29e-05	0.000119	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PPARG—thyroid cancer	6.24e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—thyroid cancer	6.11e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	6.09e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NRAS—thyroid cancer	6.07e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	6.06e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	6.04e-05	0.000114	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.03e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—NRAS—thyroid cancer	5.96e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	5.85e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—thyroid cancer	5.84e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—thyroid cancer	5.78e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	5.76e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—BRAF—thyroid cancer	5.73e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	5.68e-05	0.000107	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TPR—thyroid cancer	5.67e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	5.64e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—BRAF—thyroid cancer	5.6e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	5.6e-05	0.000106	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.58e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	5.55e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—thyroid cancer	5.53e-05	0.000104	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	5.5e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	5.44e-05	0.000103	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—RXRA—thyroid cancer	5.41e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	5.3e-05	0.0001	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PPARG—thyroid cancer	5.29e-05	9.99e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—thyroid cancer	5.27e-05	9.95e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.26e-05	9.94e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	5.25e-05	9.91e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KRAS—thyroid cancer	5.22e-05	9.86e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	5.22e-05	9.86e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	5.2e-05	9.83e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	5.2e-05	9.82e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—thyroid cancer	5.16e-05	9.74e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.16e-05	9.74e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—KRAS—thyroid cancer	5.13e-05	9.69e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—thyroid cancer	5.12e-05	9.68e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	4.93e-05	9.32e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—thyroid cancer	4.91e-05	9.27e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	4.89e-05	9.25e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—thyroid cancer	4.88e-05	9.22e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	4.86e-05	9.17e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	4.78e-05	9.03e-05	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	4.76e-05	8.99e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—thyroid cancer	4.64e-05	8.77e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	4.64e-05	8.76e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—RXRA—thyroid cancer	4.62e-05	8.74e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTEN—thyroid cancer	4.59e-05	8.68e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	4.59e-05	8.67e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	4.58e-05	8.66e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.5e-05	8.5e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTEN—thyroid cancer	4.47e-05	8.44e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	4.46e-05	8.42e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—thyroid cancer	4.44e-05	8.38e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	4.43e-05	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	4.42e-05	8.35e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—thyroid cancer	4.36e-05	8.24e-05	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	4.34e-05	8.19e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	4.32e-05	8.16e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	4.31e-05	8.14e-05	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	4.3e-05	8.12e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTEN—thyroid cancer	4.28e-05	8.09e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.25e-05	8.02e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	4.24e-05	8.02e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—thyroid cancer	4.24e-05	8.01e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—thyroid cancer	4.18e-05	7.9e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—thyroid cancer	4.16e-05	7.86e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	4.14e-05	7.83e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	4.13e-05	7.8e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—thyroid cancer	4.09e-05	7.73e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	4.06e-05	7.67e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTEN—thyroid cancer	4.04e-05	7.62e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	4.01e-05	7.58e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	4e-05	7.55e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	3.95e-05	7.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	3.95e-05	7.46e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTEN—thyroid cancer	3.95e-05	7.46e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	3.94e-05	7.45e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	3.94e-05	7.44e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—thyroid cancer	3.92e-05	7.4e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	3.9e-05	7.37e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	3.87e-05	7.31e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—thyroid cancer	3.85e-05	7.28e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	3.81e-05	7.2e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	3.74e-05	7.06e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	3.68e-05	6.95e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	3.64e-05	6.88e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTEN—thyroid cancer	3.63e-05	6.85e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	3.61e-05	6.82e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—thyroid cancer	3.6e-05	6.8e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	3.59e-05	6.78e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—RXRA—thyroid cancer	3.57e-05	6.74e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	3.57e-05	6.74e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—thyroid cancer	3.52e-05	6.65e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	3.51e-05	6.63e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—thyroid cancer	3.42e-05	6.45e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	3.4e-05	6.43e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	3.38e-05	6.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	3.35e-05	6.33e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	3.33e-05	6.3e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	3.28e-05	6.2e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	3.27e-05	6.17e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	3.26e-05	6.16e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	3.19e-05	6.02e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	3.14e-05	5.94e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—thyroid cancer	3.1e-05	5.85e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	3.07e-05	5.8e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	3.03e-05	5.73e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—thyroid cancer	3.03e-05	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	3.02e-05	5.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	2.96e-05	5.59e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—thyroid cancer	2.92e-05	5.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	2.91e-05	5.5e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	2.89e-05	5.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	2.87e-05	5.42e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	2.82e-05	5.33e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—thyroid cancer	2.75e-05	5.2e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	2.73e-05	5.16e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	2.71e-05	5.11e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—thyroid cancer	2.69e-05	5.09e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.69e-05	5.08e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—thyroid cancer	2.65e-05	5e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—thyroid cancer	2.63e-05	4.98e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	2.61e-05	4.93e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—thyroid cancer	2.58e-05	4.87e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—thyroid cancer	2.57e-05	4.86e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	2.55e-05	4.82e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	2.55e-05	4.82e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	2.51e-05	4.74e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	2.51e-05	4.74e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—thyroid cancer	2.47e-05	4.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	2.44e-05	4.61e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	2.4e-05	4.53e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTEN—thyroid cancer	2.34e-05	4.43e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	2.33e-05	4.4e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—thyroid cancer	2.33e-05	4.39e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	2.3e-05	4.35e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.3e-05	4.34e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—thyroid cancer	2.28e-05	4.3e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—thyroid cancer	2.25e-05	4.26e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	2.23e-05	4.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	2.15e-05	4.07e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	2.13e-05	4.03e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	2.12e-05	4e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—thyroid cancer	2.09e-05	3.95e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	2.07e-05	3.91e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTEN—thyroid cancer	2e-05	3.78e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	1.98e-05	3.74e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	1.88e-05	3.56e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.77e-05	3.35e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	1.75e-05	3.3e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.55e-05	2.92e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—thyroid cancer	1.35e-05	2.55e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—thyroid cancer	1.15e-05	2.18e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—thyroid cancer	8.91e-06	1.68e-05	CbGpPWpGaD
